PIERONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.690
EU - Europa 3.320
AS - Asia 1.393
SA - Sud America 198
Continente sconosciuto - Info sul continente non disponibili 89
AF - Africa 58
Totale 8.748
Nazione #
US - Stati Uniti d'America 3.625
IT - Italia 1.083
RU - Federazione Russa 513
GB - Regno Unito 497
CN - Cina 483
SG - Singapore 403
IE - Irlanda 356
SE - Svezia 201
VN - Vietnam 172
BR - Brasile 159
DE - Germania 159
UA - Ucraina 157
FR - Francia 142
HK - Hong Kong 112
FI - Finlandia 82
KR - Corea 40
ES - Italia 39
BD - Bangladesh 38
CA - Canada 36
IN - India 32
TR - Turchia 27
ZA - Sudafrica 24
BE - Belgio 22
MX - Messico 17
JP - Giappone 16
PL - Polonia 16
IQ - Iraq 14
AR - Argentina 12
CZ - Repubblica Ceca 10
MA - Marocco 8
AT - Austria 7
EC - Ecuador 7
LT - Lituania 7
PK - Pakistan 7
CL - Cile 6
ID - Indonesia 6
IR - Iran 6
CI - Costa d'Avorio 5
LB - Libano 5
NG - Nigeria 5
CO - Colombia 4
NL - Olanda 4
PH - Filippine 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.663
Città #
Southend 433
Fairfield 374
Dublin 353
Dallas 352
Ashburn 278
Singapore 242
Chandler 198
Santa Clara 176
Woodbridge 161
Seattle 152
San Jose 150
Moscow 149
Beijing 145
Wilmington 143
Houston 142
Jacksonville 130
Ann Arbor 125
Cambridge 110
Milan 108
Siena 106
Hong Kong 104
Council Bluffs 80
Princeton 64
Helsinki 52
Ho Chi Minh City 51
Hefei 50
Los Angeles 48
Rome 47
Florence 46
New York 44
Dearborn 43
Lastra a Signa 40
Seoul 38
Nanjing 37
Hanoi 35
Lauterbourg 33
The Dalles 32
San Mateo 30
Catania 28
Munich 26
Málaga 24
Boardman 23
Johannesburg 23
Shanghai 23
Gavirate 22
San Diego 22
Izmir 19
Nanchang 18
Buffalo 16
Changsha 14
Tokyo 14
Chicago 13
Columbus 13
Orem 13
Toronto 13
Da Nang 12
Phoenix 12
Shenyang 12
São Paulo 12
Warsaw 12
Dong Ket 11
Frankfurt am Main 11
Fremont 11
San Francisco 11
Brussels 10
Hebei 10
Montreal 10
Trieste 10
Baghdad 9
Boston 9
Chennai 9
Düsseldorf 9
Figino 9
Montecatini Terme 9
Prato 9
Redondo Beach 9
Venezia 9
Napoli 8
Haiphong 7
Jiaxing 7
Kunming 7
Mexico City 7
Norwalk 7
Poplar 7
Arezzo 6
Brno 6
Denver 6
Figline Valdarno 6
Grosseto 6
Madrid 6
Manchester 6
Menlo Park 6
Ningbo 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Abidjan 5
Abuja 5
Belo Horizonte 5
Bengaluru 5
Totale 5.592
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.062
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 356
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 306
Exhaled nitric oxide in interstitial lung diseases 278
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 263
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 259
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 258
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 256
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 246
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 245
Could NSAIDs have a role as antiasthmatic agents? 236
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 234
NK and NKT-like cells in granulomatous and fibrotic lung diseases 231
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 228
Chitotriosidase: a sensitive biomarker of sarcoidosis 224
The analysis of tryptase in serum of sarcoidosis patients 222
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 221
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 220
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 217
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 215
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 214
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 213
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 199
Inhaled loop diuretics as potential new anti-asthmatic drugs 198
IPF mortality in waiting list for lung transplantation 193
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 188
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 188
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 185
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 178
Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions 161
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 149
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 142
Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H2O. A dose-response study 141
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 132
null 121
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 114
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 100
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 80
The value of urinary calcium as biomarker in chronic sarcoidosis 38
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 37
Totale 8.748
Categoria #
all - tutte 24.873
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.873


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022495 0 69 41 58 18 11 32 21 12 51 67 115
2022/2023666 44 69 80 85 63 134 19 46 70 32 16 8
2023/2024561 15 14 46 23 22 141 199 19 4 18 6 54
2024/2025972 55 46 104 35 138 60 56 39 38 46 108 247
2025/20262.571 180 310 270 308 515 88 316 54 78 136 89 227
2026/2027155 77 78 0 0 0 0 0 0 0 0 0 0
Totale 8.748